title: Effects of excitatory amino acids on inositol phosphate accumulation in slices of the cerebral cortex of young and aged rats.
abstract: The effects of glutamate, NMDA and quisqualate on carbachol- and norepinephrine-elicited formation of inositol phosphate (IP) were evaluated in slices prepared from the cerebral cortex of 3- and 24-month Sprague-Dawley rats. Glutamate, NMDA, and quisqualate antagonized the IP response to carbachol in a concentration-dependent fashion. This antagonism was more pronounced in aged than in young rats, both for glutamate (IC5O 0.114 and 0.210 mM) and NMDA (IC5O 0.0029 and 0.127 mM), but not for quisqualate. Glutamate (but not NMDA) also antagonized in a concentration-dependent fashion the IP response to norepinephrine, IC50s were 0.061 and 0.126 mM for aged and young rats, respectively; quisqualate had an inhibitory effect only at 1 mM concentration in the two age-groups, while in aged rats some stimulatory effect was present at 0.1 mM concentration. Glutamate, NMDA and quisqualate (1 mM) did not affect basal IP accumulation in either young or aged rats; quisqualate, however, at 0.1 mM concentration had some stimulatory effect, more pronounced in aged rats. This effect was probably responsible for the biphasic effect of quisqualate in this age-group. The most important finding consists of the demonstration of an age-related increase in the inhibitory effects of NMDA on carbachol-induced IP accumulation. This implies an altered modulation of cholinergic post-receptor mechanisms by glutamatergic mechanisms.
authors.affiliation: Laboratory of Pharmacology, Istituto Superiore di Sanità, Rome, Italy.
authors.forename: I
authors.initials: I
authors.lastname: Nalepa
authors.forename: A
authors.initials: A
authors.lastname: Pintor
authors.forename: E
authors.initials: E
authors.lastname: Chalecka-Franaszek
authors.forename: S
authors.initials: S
authors.lastname: Fortuna
authors.forename: H
authors.initials: H
authors.lastname: Michalek
authors.forename: J
authors.initials: J
authors.lastname: Vetulani
mesh_terms: D000375:Aging / Q000378:metabolism*; D000596:Amino Acids / Q000494:pharmacology*; D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism*; D005971:Glutamates / Q000494:pharmacology; D018698:Glutamic Acid; D007295:Inositol Phosphates / Q000378:metabolism*; D008297:Male; D016202:N-Methylaspartate / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D016318:Quisqualic Acid / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000596:Amino Acids; D005971:Glutamates; D007295:Inositol Phosphates; D018698:Glutamic Acid; D016202:N-Methylaspartate; D016318:Quisqualic Acid; D002217:Carbachol; D009638:Norepinephrine